Hi Supertramp, I hear you... losing a patient to an unexpected death in a trial would be devastating in most trials. However, some of the patients in our trials are already very ill and if some pass away, sadly, it would be just another statistical event. A point on a graph. Horrific but true. I am more concerned about unexplained side effects, but what do you compare it with ....chemo ? It seems even the worst side effects would be comparable with SOC treatment.
Imugene Price Target Raised 47% to A$0.25/Share by Bell Potter, page-37
-
- There are more pages in this discussion • 174 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
-0.002(4.26%) |
Mkt cap ! $334.7M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.8¢ | 4.4¢ | $890.8K | 19.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 176601 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 877572 | 7 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |